Strong Industry Recognition Protagonist's recent FDA approval and subsequent milestone payments highlight its emerging presence in the pharmaceutical and biotech sectors, presenting opportunities for partnerships and licensing deals with healthcare providers and pharmaceutical companies.

Innovative Product Pipeline With its flagship product ICOTYDE demonstrating promising clinical results and a differentiated oral delivery method, there is a clear sales potential for engaging healthcare professionals and clinics specializing in dermatology and systemic therapies.

Strategic Collaborations Protagonist's partnership with Johnson & Johnson and focus on competing with established brands like AbbVie's Skyrizi suggest an openness to collaborative ventures, joint marketing efforts, and co-promotional opportunities within the dermatology therapeutic market.

Emerging Market Footprint The company's recent positive clinical data and FDA approvals position it for rapid scaling, creating opportunities to introduce its innovative therapies to hospital systems, specialty clinics, and health networks looking for advanced treatment options for plaque psoriasis.

Market Penetration Potential Given the company's focus on novel oral treatments with a favorable safety profile, there is significant sales potential in targeting patient populations seeking effective and convenient therapies, as well as health insurers interested in supporting cost-effective treatment solutions.